Test Price
2,800 AEDโ Home Collection Available
JAK2 Somatic Mutation Analysis (Myelofibrosis) โ Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing (Certificate: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic post-test guidance with clinical correlation support.
- Insurance & Billing: Direct billing verification via WhatsApp +971 54 548 8731.
Compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the Use of Information and Communication Technology in Health Fields. Clinical safety adheres to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Test Overview & Methodology
This JAK2 Somatic Mutation Analysis uses Next-Generation Sequencing (NGS) to detect acquired mutations in the JAK2 gene, primarily V617F, associated with myelofibrosis and other myeloproliferative neoplasms. The test provides single-nucleotide resolution with coverage of multiple mutation hotspots for precise diagnosis and treatment guidance.
| Feature | Our Test (JAK2 NGS Panel) | Standard Allele-Specific PCR |
|---|---|---|
| Precision | Single-nucleotide resolution, multi-mutation coverage | Limited to pre-defined mutations (e.g., V617F only) |
| Methodology | Next-Generation Sequencing (NGS) | Allele-specific PCR |
| Turnaround Time | 3โ4 Weeks (Thorough bioinformatics) | 3โ7 Days |
| Clinical Utility | Comprehensive somatic profiling for treatment decisions | Preliminary screening |
Physician Insight & Safety Protocols
โUnderstanding the genetic landscape of your myelofibrosis can be overwhelming, but it is a critical step toward personalized therapy. This NGS test uncovers key drivers like JAK2 mutations, enabling your oncologist to tailor treatments such as JAK inhibitors. Please remember that every result must be clinically correlated with symptoms and other lab findings; never interpret results in isolation.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory & Safety Precautions
โ ๏ธ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. This test is for diagnostic guidance and does not replace medical advice.
Exclusion & Emergency Red Flags
- This test is not for emergency diagnosis of acute thrombotic or hemorrhagic events.
- Seek immediate medical attention if you experience sudden severe abdominal pain (possible splenic rupture), uncontrollable bleeding, or signs of stroke.
- Not suitable for standalone screening without clinical context; genetic counseling is recommended.
Patient FAQ & Clinical Guidance
1. What is the JAK2 somatic mutation test, and why is it done?
A: This test identifies somatic JAK2 mutations driving myelofibrosis using advanced NGS for precise diagnosis and monitoring. It helps confirm myelofibrosis and guides targeted therapies such as JAK inhibitors.
2. How should I prepare for the test, and what samples are accepted?
A: No fasting or special preparation is needed. Accepted sample types: whole blood, extracted DNA, or a dried blood spot on an FTA card. For home collection, a trained phlebotomist will collect whole blood under cold chain conditions.
3. Is the JAK2 mutation test covered by insurance in the UAE?
A: Many UAE insurers cover medically necessary NGS testing for myelofibrosis. Verify your coverage with our direct billing support via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
All clinical data handling complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the use of information and communication technology in health fields. Patient consent and clinical safety are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Your sample and results are processed under strict confidentiality and secure storage protocols.
Clinical & Logistical Metadata
| Test Name | JAK2 Somatic Mutation Analysis (Myelofibrosis) โ NGS |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | D47.1 (Myelofibrosis) |
| LOINC Code | 42821-9 (JAK2 gene mutation analysis in Blood) |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians